shaimaa Mostafa
Cairo, Egypt
NCT Number: NCT04228874
the effect of stent size and number on left ventricular mechanical dyssynchrony after PCI using drug eluting stent is not clear enough
Looking for future studies?
Notify Me18 year–75 year
All sexes
Observational
Cairo, Egypt
Background: the effect of stent size and number on left ventricular mechanical dyssynchrony after PCI using drug eluting stent is not clear enough Aim: to study short term effect of stent size and number on left ventricular mechanical dyssynchrony after elective PCI to LAD artery.
Patients and methods: the study included 150 adult patients with electively stented LAD lesion with DES. Patients were evaluated pre PCI then follow up at 1m and 3m using tissue synchronization image (TSI).
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Coronary angiography was done for all the patients according to the Judkins technique. All images were evaluated by an experienced operator, significant coronary artery disease was defined as > 70 % luminar diameter stenos. The following data was obtained:
Time frame: 3 months
Benha University
Other
The Short Term Effect of Stent Size and Number on Left Ventricular Mechanical Dyssynchrony After Elective PCI to Left Anterior Descending Artery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07090720
Left Ventricular Function, Melatonin
Tanta, El-Gharbia, Egypt
View Trial DetailsNCT01526252
Left Ventricular Function
Ottawa, Ontario, Canada
View Trial DetailsNCT06509074
Acute Coronary Syndrome, Beta-blockers
Madrid, Spain
View Trial Details